Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
216
currently held
Exits tracked
96
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin267 companies matching · Page 6 of 6
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Oria Bioscience Newfund HEKA | Newfund Management | 2025 | 1yr | Active | – | – | |||
Osivax CapHorn 2 | CapHorn | – | – | Active | – | – | |||
PALUMED S.A IRDInov 3 | Irdi Capital-Investissement | 2002 | – | Exited | – | – | |||
PEP-Therapy CapHorn 2 | CapHorn | – | – | Active | – | – | |||
Pepkon Aloe Environment Fund III | Aloe Private Equity | 2019 | 7yr | Active | – | – | |||
Persea Erganeo | Erganeo | 2022 | 4yr | Active | – | – | |||
Polygon Therapeutics Sorbonne Venture by Audacia | Audacia | 2024 | 2yr | Active | – | – | |||
QBio JRC Elaia Endowment Fund | Elaia Partners | 2022 | 4yr | Active | – | – | |||
Ribonexus AFB Fund II | AdBio Partners | 2021 | 5yr | Active | – | – | |||
SideROS Erganeo | Erganeo | 2019 | 7yr | Active | – | – | |||
Sim&Cure Elaia Delta Fund | Elaia Partners | 2019 | 7yr | Active | – | – | |||
Stroma Care Capital Santé 2 | Turenne Groupe | 2022 | 4yr | Active | – | – | |||
Stromacare Capital Santé 2 | Turenne Groupe | 2022 | 4yr | Active | – | – | |||
Synboli AVA 1 (Aquiti Venture Amorcage) | Aquiti Gestion | 2025 | 1yr | Active | – | – | |||
Targedys Health for Life Capital | Seventure Partners | 2019 | 7yr | Active | – | – | |||
Ternary Therapeutics Daphni Blue | Daphni | 2025 | 1yr | Active | – | – | |||
Yukin Therapeutics AFB Seed-Fund | AdBio Partners | 2019 | 7yr | Active | – | – |
Oria Bioscience
Newfund HEKA
FranceSector
Biotech
InvestorNewfund Management
Entry
2025
Hold
1yr
Osivax
CapHorn 2
FranceSector
Biotech
InvestorCapHorn
Entry
–
PALUMED S.A
IRDInov 3
FranceSector
Biotech
InvestorIrdi Capital-Investissement
Entry
2002
PEP-Therapy
CapHorn 2
FranceSector
Biotech
InvestorCapHorn
Entry
–
Pepkon
Aloe Environment Fund III
FranceSector
Biotech
InvestorAloe Private Equity
Entry
2019
Hold
7yr
Persea
Erganeo
FranceSector
Biotech
InvestorErganeo
Entry
2022
Hold
4yr
Polygon Therapeutics
Sorbonne Venture by Audacia
FranceSector
Biotech
InvestorAudacia
Entry
2024
Hold
2yr
QBio JRC
Elaia Endowment Fund
FranceSector
Biotech
InvestorElaia Partners
Entry
2022
Hold
4yr
Ribonexus
AFB Fund II
FranceSector
Biotech
InvestorAdBio Partners
Entry
2021
Hold
5yr
SideROS
Erganeo
FranceSector
Biotech
InvestorErganeo
Entry
2019
Hold
7yr
Sim&Cure
Elaia Delta Fund
FranceSector
Biotech
InvestorElaia Partners
Entry
2019
Hold
7yr
Stroma Care
Capital Santé 2
FranceSector
Biotech
InvestorTurenne Groupe
Entry
2022
Hold
4yr
Stromacare
Capital Santé 2
FranceSector
Biotech
InvestorTurenne Groupe
Entry
2022
Hold
4yr
Synboli
AVA 1 (Aquiti Venture Amorcage)
FranceSector
Biotech
InvestorAquiti Gestion
Entry
2025
Hold
1yr
Targedys
Health for Life Capital
FranceSector
Biotech
InvestorSeventure Partners
Entry
2019
Hold
7yr
Ternary Therapeutics
Daphni Blue
FranceSector
Biotech
InvestorDaphni
Entry
2025
Hold
1yr
Yukin Therapeutics
AFB Seed-Fund
FranceSector
Biotech
InvestorAdBio Partners
Entry
2019
Hold
7yr